Heartflow, Inc. Unrealized Gain (Loss) on Derivatives
Heartflow, Inc. (HTFL) reported Unrealized Gain (Loss) on Derivatives of $7.31 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-18.
Financial Statements › Cash Flow › Operating Activities
us-gaap:UnrealizedGainLossOnDerivatives · last filed 2026-08-13
- Heartflow, Inc. unrealized gain (loss) on derivatives for the quarter ending 2025-12-31 was $0.00.
- Heartflow, Inc. unrealized gain (loss) on derivatives for the quarter ending 2025-09-30 was $4.82M.
- Heartflow, Inc. unrealized gain (loss) on derivatives for the quarter ending 2025-06-30 was $11.54M.
- Heartflow, Inc. unrealized gain (loss) on derivatives for the quarter ending 2025-03-31 was -$9.04M.
- Heartflow, Inc. unrealized gain (loss) on derivatives for fiscal 2025 was $7.31M.
- Heartflow, Inc. unrealized gain (loss) on derivatives for fiscal 2024 was -$222.00K, a 105.34% decline from fiscal 2023.
- Heartflow, Inc. unrealized gain (loss) on derivatives for fiscal 2023 was $4.16M.
| Period end | Unrealized Gain (Loss) on Derivatives | Unrealized Gain (Loss) on Derivatives 3 month | Unrealized Gain (Loss) on Derivatives 6 month | Unrealized Gain (Loss) on Derivatives 9 month | Unrealized Gain (Loss) on Derivatives 12 month |
|---|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $4.82M derived: sum of 2 quarters · filed 2026-03-18 | $16.36M derived: sum of 3 quarters · filed 2026-08-13 | $7.31M 10-K · filed 2026-03-18 | |
| 2025-09-30 | $4.82M 10-Q · filed 2025-11-12 | $16.36M derived: sum of 2 quarters · filed 2026-08-13 | $7.31M 10-Q · filed 2025-11-12 | $7.31M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-06-30 | $11.54M 10-Q · filed 2026-08-13 | $2.49M 10-Q · filed 2026-08-13 | $2.49M derived: sum of 3 quarters · filed 2026-08-13 | $2.49M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-03-31 | -$9.04M 10-Q · filed 2026-05-14 | -$9.04M derived: sum of 2 quarters · filed 2026-05-14 | -$9.04M derived: sum of 3 quarters · filed 2026-05-14 | -$9.21M derived: sum of 4 quarters · filed 2026-05-14 | |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $0.00 derived: sum of 2 quarters · filed 2026-03-18 | -$161.00K derived: sum of 3 quarters · filed 2026-03-18 | -$222.00K 10-K · filed 2026-03-18 | |
| 2024-09-30 | $0.00 10-Q · filed 2025-11-12 | -$161.00K derived: sum of 2 quarters · filed 2025-11-12 | -$222.00K 10-Q · filed 2025-11-12 | ||
| 2024-06-30 | -$161.00K 10-Q · filed 2025-09-19 | -$222.00K 10-Q · filed 2025-09-19 | |||
| 2024-06-14 | -$222.00K 10-K · filed 2026-03-18 | ||||
| 2023-12-31 | $4.20M 10-K · filed 2026-03-18 | $4.16M 10-K · filed 2026-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |